A National Multicenter Phase 2 Study of Prostate-specific Antigen (PSA) Pox Virus Vaccine with Sequential Androgen Ablation Therapy in Patients with PSA Progression: ECOG 9802

BACKGROUND: E9802 was a phase 2 multi-institution study conducted to evaluate the safety and effectiveness of vaccinia and fowlpox prostate-specific antigen (PSA) vaccine (step 1) followed by combination with androgen ablation therapy (step 2) in patients with PSA progression without visible metasta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Eur Urol
Hauptverfasser: DiPaola, Robert S., Chen, Yu-Hui, Bubley, Glenn J., Stein, Mark N., Hahn, Noah M., Carducci, Michael A., Lattime, Edmund C., Gulley, James, Arlen, Philip M., Butterfield, Lisa H., Wilding, George
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4472612/
https://ncbi.nlm.nih.gov/pubmed/25533418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2014.12.010
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge